![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/44 | (2006.01) |
C07D 491/14 | (2006.01) | ||
A61K 31/527 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2968290 |
(13) | Kind of document | T |
(96) | European patent application number | 14762438.1 |
Date of filing the European patent application | 2014-03-14 | |
(97) | Date of publication of the European application | 2016-01-20 |
(45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
(46) | Date of publication of the claims translation | 2019-12-10 |
(86) | Number | PCT/US2014/028685 |
Date | 2014-03-14 |
(87) | Number | WO 2014/144326 |
Date | 2014-09-18 |
(30) | Number | Date | Country code |
201361798772 P | 2013-03-15 | US | |
201361861374 P | 2013-08-01 | US | |
201361911354 P | 2013-12-03 | US | |
201461949786 P | 2014-03-07 | US |
(72) |
STRUM, Jay, Copeland, US
BISI, John, Emerson, US
ROBERTS, Patrick, Joseph, US
TAVARES, Francis, Xavier, US
|
(73) |
G1 Therapeutics, Inc.,
79 T.W. Alexander Drive 4501 Research Commons, Suite 100, Research Triangle Park, NC 27709,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Laikina normalių ląstelių apsauga chemoterapijos metu |
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY |
Payment date | Validity (years) | Amount | |
2025-01-21 | 12 | 289.00 EUR |
2026-03-14 |